Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IM862 in AIDS-related Kaposi's Sarcoma
NCT00002445Phase 3Completed
- Sponsor
- Cytran
- Modality
- Peptides, Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of oglufanide disodium in Kaposi's sarcoma (KS), sponsored by Cytran. Status: completed.
02
Drugs
oglufanide disodium
03
Conditions
Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT00002445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002445.